Delivery Order SPE2DB22D3301-SPE2DB24FY5TX
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,916.92, is a firm fixed-price delivery order for the supply of 4565058004 - Bupropion HCL XL 300 mg Tablets in 500 count bottles. The contract has an ultimate completion date of July 3, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, valued at $13,575.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4563654049 - BUPROPION HCL XL 300 MG TABLET 500S, with an ultimate completion date of February 14, 2024. The contract is a firm fixed-price award and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,068.28 firm-fixed-price delivery order is for the supply of Bupropion HCL XL 300 MG tablets. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award, valued at $86,361.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order contract with a Firm Fixed Price pricing type and an ultimate completion date of January 24, 2024. The contract covers the delivery of 4563416633 - BUPROPION HCL XL 150 MG TABLET 500S, a generic pharmaceutical product, to support military and government healthcare...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,539.90 firm fixed-price delivery order is for the supply of 500 count BUPROPION HCL XL 150 MG tablets. The contract has an ultimate completion date of January 18, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of BUPROPION HCL XL 300 MG TABLET 500S. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $105,516.75 and a performance period ending on February 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,596.22, is for the delivery of bupropion HCL XL 300 mg tablets. The contract is a firm fixed-price delivery order that runs through January 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $12,620.33, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,077,741 tablets of Bupropion HCL XL 300 mg. The contract is a firm fixed-price delivery order with a performance period ending on April 30, 2025. This award is not designated as a set-aside and represents an open competition contract. Amerisourcebergen Drug Corp is a significant vendor for the DLA,...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $28,660.47 firm fixed-price delivery order is for 4,563,336,728 BUPROPION HCL XL 300 MG TABLETS, with a completion date of January 17, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a comprehensive vehicle for...
- This federal contract award is for the delivery of 500 tablets of Bupropion HCL XL 300 mg, a prescription medication, to the Defense Logistics Agency (DLA). The award is a Firm Fixed Price Delivery Order with a ceiling value of $12,695.46 and an ultimate completion date of July 11, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and represents open competition. Amerisourcebergen Drug...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY5TXDelivery Order
This federal contract award, identified as SPE2DB22D3301|SPE2DB24FY5TX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $60,324.77, is for the delivery of 4564438114 - BUPROPION HCL XL 300 MG TABLET 500S, a generic medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2024. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific award is not associated with a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $60.3k | 4/29/24 |